Gene alteration affects psychosis in young cannabis users

Adolescent male mice are particularly susceptible to cannabis-induced psychosis, reports a study published online this week in Neuropsychopharmacology, indicating that age at exposure and genotype are important factors.

Gene alteration affects psychosis in young cannabis users
DOI: 10.1038/NPP.2010.100

While there is a well-recognized association between cannabis use and psychotic illness, the mechanism that confers individual risk is not yet fully understood. Adolescent male mice are particularly susceptible to cannabis-induced psychosis, reports a study published online this week in Neuropsychopharmacology, indicating that age at exposure and genotype are important factors. The underlying mechanism appears to involve a variant in the gene for catechol-O-methyltransferase (COMT), which breaks down dopamine.

Colm O’Tuathaigh and colleagues subjected mice lacking the COMT gene to chronic THC exposure – a component of cannabis already thought to be involved in psychosis – during either adolescence or adulthood. Their adult behavioral phenotypes were then measured and assessed for signs of psychosis. Adolescent THC exposure in mice lacking the COMT gene modified exploratory activity, spatial working memory and anxiety-related behaviors, particularly in male mice.

These findings indicate a genetic influence that, together with developmental factors, contributes to the vulnerability of adolescent cannabis users to psychosis. The authors caution, however, that future studies will be needed to confirm whether these findings are applicable to humans.

Author contact:
Colm O’Tuathaigh (Royal College of Surgeons in Ireland, Dublin, Ireland)
Tel: +35 31 402 2377
E-mail: [email protected]

Editorial contact:
Diane Drexler (Neuropsychopharmacology, Nashville, TN, USA)
Tel: +1 615 324 2371
E-mail: [email protected]

Press contacts:

For media inquiries relating to embargo policy for the Journal Neuropsychopharmacology:

Neda Afsarmanesh (Nature New York)
Tel: +1 212 726 9231
E-mail: [email protected]

Rachel Twinn (Nature London)
Tel: +44 20 7843 4658
E-mail: [email protected]

About Nature Publishing Group (NPG)

Nature Publishing Group (NPG) is a publisher of high impact scientific and medical information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences and clinical medicine.

Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. In addition, for this audience, NPG publishes a range of Nature research journals and Nature Reviews journals, plus a range of prestigious academic journals including society-owned publications. Online, nature.com provides over 5 million visitors per month with access to NPG publications and online databases and services, including Nature News and NatureJobs plus access to Nature Network and Nature Education’s Scitable.com.

Scientific American is at the heart of NPG’s newly-formed consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 15 local language editions around the world it reaches over 3 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.

Throughout all its businesses NPG is dedicated to serving the scientific and medical communities and the wider scientifically interested general public. Part of Macmillan Publishers Limited, NPG is a global company with principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.

Published: 14 Jul 2010

Contact details:

The Macmillan Building, 4 Crinan Street
London
N1 9XW
United Kingdom

+44 20 7833 4000
Country: 
Journal:
News topics: 
Content type: 
Websites: